Trilipix (AbbVie Inc.)
Welcome to the PulseAid listing for the Trilipix drug offered from AbbVie Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Fenofibric Acid |
| SUBSTANCE NAME: | FENOFIBRIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-09-12 |
| END MARKETING DATE: | 0000-00-00 |
Trilipix HUMAN PRESCRIPTION DRUG Details:
| Item Description | Trilipix from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 45(mg/1) |
| START MARKETING DATE: | 2016-09-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-3161_a334aec5-8e67-3541-088c-3afc4c2c4e33 |
| PRODUCT NDC: | 0074-3161 |
| APPLICATION NUMBER: | NDA022224 |
Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers:
